Which breathing aid works best after surgery? new trial aims to find out

NCT ID NCT06988111

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two noninvasive breathing devices—BIPAP and a high-velocity nasal cannula—to see which helps patients recover faster from respiratory failure after major surgery. About 180 adults who develop breathing problems within 48 hours after surgery will be randomly assigned to one of the two devices. The main goal is to see how many days it takes for each patient to no longer need breathing support.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Breathing devices (BIPAP and Vapotherm)
What this could lead to
If successful, this could show which device helps patients recover faster and avoid invasive breathing tubes after surgery.
What could go wrong
This is a single-center trial with 180 participants, so results may not apply to all hospitals. The study is early and does not test a new drug or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE RESPIRATORY COMPLICATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Assuit Univeristy

    RECRUITING

    Asyut, Assuit, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.